Zydus Lifesciences Limited is a global life sciences company based in India that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare therapies. The company operates in the business of integrated pharmaceutical operations, offering a diverse product portfolio that includes active pharmaceutical ingredients (API), human formulations, animal health and veterinary products, as well as health and wellness products.
The company’s product portfolio is categorized into several segments, including India formulations, generics, and Zydus biologics. Some of its notable products include Lipaglyn and Bilypsa (Saroglitazar), which are used to treat various health conditions. Additionally, the company offers a range of biosimilars, such as Ujvira (Trastuzumab emtansine biosimilar), Exemptia (Adalimumab biosimilar), Vivitra (Trastuzumab biosimilar), and Bryxta (Bevacizumab biosimilar), which are used to treat various diseases, including cancer and autoimmune disorders.
Zydus biologics, a key segment of the company, covers a wide range of therapeutic areas, including oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses, among others. The company’s products are designed to provide effective treatment options for patients with various health conditions, and its biosimilars are developed to be more affordable and accessible alternatives to traditional biologic therapies.
With a global presence, Zydus Lifesciences Limited markets its products in several key regions, including the United States, India, Europe, and emerging markets. The company’s global reach and diverse product portfolio have established it as a significant player in the global life sciences industry. Through its commitment to innovation and quality, Zydus Lifesciences Limited aims to provide effective and affordable healthcare solutions to patients around the world. Overall, the company’s broad range of products and global presence have positioned it for continued growth and success in the life sciences industry.